Convatec Group PLC

Research Convatec Group PLC (CTEC.L) with Bullrun company financials, valuation charts, model signals, and historical stock context.

Key Metrics

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 2.44BUSD 175.00MUSD 285.00M56.2%0.09USD 68.00MUSD 1.52BUSD 1.52B
FY2024USD 2.29BUSD 191.00MUSD 275.00M56.1%0.09USD 65.00MUSD 1.20BUSD 1.69B
FY2023USD 2.14BUSD 130.30MUSD 238.20M56.0%0.06USD 97.60MUSD 1.31BUSD 1.69B
FY2022USD 2.07BUSD 62.90MUSD 137.50M53.3%0.03USD 143.80MUSD 1.30BUSD 1.61B

Dividend history

YearDividends/share
FY20250.06 USD
FY20240.06 USD
FY20230.06 USD
FY20220.05 USD
FY20210.05 USD

About Convatec Group PLC

Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.

Related stock research

Other Healthcare stocks

Frequently asked questions

What does Convatec Group PLC do?

Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.